Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
Topics Covered
- Adjuvant
- Excipient
- Gene therapy
- Nanoparticle
- Particle size
- Production
- Solubilization
- Scaling up
Biography
Dr. Shaukat Ali is Sr. Director of Scientific Affairs and Technical Marketing at Ascendia Pharma as, with three decades of experience in the pharmaceutical industry. He has held several key roles in the industry with increasing responsibilities in the areas of synthesis, formulations and drug development. His expertise in the excipients and innovative solubilization technologies including amorphous solid dispersions, lipid based self-emulsifying drug delivery systems and lipid and polymeric nanoparticles for orals, and liposomes for parenteral delivery has led to development, and marketing of a many poorly soluble drug molecules. Dr. Ali has worked as the technical expert with a number of biopharma, ethical and generic pharma companies over the years and has helped the scientists working with innovative molecules in early phase preclinical and clinical developments of molecules across all modalities.
Dr. Ali received his PhD in Organic Chemistry from the City University of New York, NY, and carried out his postdoctoral work at the University of Minnesota and Cornell University. Dr. Ali served as a member of the editorial advisory board of American Pharma Review, Drug Development and Delivery, Contract Pharma, Biopharma Asia among others, and also serving as the Editor-In-Chief of Journal of Analytical and Pharmaceutical Research. Dr. Ali is also a member of USP Council of Expert for Excipient Test Methods committee. Dr. Ali is the recipient of IPEC Foundation’s 2020 Henk de Jong industrial research award for his contributions to formulations and excipient technologies. He has published over 60 articles in scientific journals and an inventor of several US and European patents. Dr. Ali is also an AAPS Fellow.
Talk Citation
Ali, S. (2024, March 21). Challenges and solutions of scaling up [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 12, 2024, from https://doi.org/10.69645/WOIR2470.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Shaukat Ali has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.